Identifying key parts of viruses that could cause pandemics
THE IDENTIFICATION AND VALIDATION OF EPITOPES CONSERVED IN VIRAL PATHOGEN FAMILIES WITH PANDEMIC POTENTIAL
['FUNDING_OTHER'] · LA JOLLA INSTITUTE FOR IMMUNOLOGY · NIH-11203574
This study is looking for common parts of certain viruses that could help create vaccines or treatments for future pandemics, so that people can be better protected against illnesses like COVID-19 and others.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | LA JOLLA INSTITUTE FOR IMMUNOLOGY (nih funded) |
| Locations | 1 site (LA JOLLA, UNITED STATES) |
| Trial ID | NIH-11203574 on ClinicalTrials.gov |
What this research studies
This research focuses on identifying and validating specific parts of viruses that are common across families known to have pandemic potential. By selecting prototype viruses from families such as Coronaviridae, Flaviviridae, and others, the research aims to screen for these conserved epitopes. This could help in developing vaccines or treatments that are effective against multiple viruses within these families. Patients may benefit from advancements in vaccine development and improved preparedness for future pandemics.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals at risk for infections from viruses like SARS-CoV-2, Dengue, Chikungunya, Measles, Lassa, and Poliovirus.
Not a fit: Patients who are not at risk for these specific viral infections may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of vaccines that protect against multiple viral infections with pandemic potential.
How similar studies have performed: Other research has shown success in identifying conserved viral epitopes, indicating that this approach has potential for significant advancements in pandemic preparedness.
Where this research is happening
LA JOLLA, UNITED STATES
- LA JOLLA INSTITUTE FOR IMMUNOLOGY — LA JOLLA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: FABRITZKY, BRANDON — LA JOLLA INSTITUTE FOR IMMUNOLOGY
- Study coordinator: FABRITZKY, BRANDON
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.